Skip to main content

ENGLISH · EVIDENCE OVERVIEW

Lidocaine + Prilocaine
evidence profile

Topical amide local anaesthetic combination / sodium-channel blocker. This is a concise English overview, not a full translation. Read the evidence boundaries and original sources below; the detailed study and risk discussion remains available in Thai.

What do Class, Grade and Risk mean?

Lidocaine + Prilocaine: conceptual scientific illustration for Sexual Medicine Pharmacology
VISUAL GUIDE · Lidocaine + Prilocaine

Sexual Medicine Pharmacology

Category-level conceptual illustration, not a map of this molecule's receptor targets. It is not a treatment outcome and does not establish efficacy or safety.

QUICK ANSWER · AEO / GEO

A topical amide local-anaesthetic combination; the specific Fortacin product is authorised in the EU for primary lifelong premature ejaculation in adult men, without extending that status to every cream or spray.

01

ENTITY FACTS

What should readers identify first?

MOLECULELidocaine + Prilocaine
PHARMACOLOGYTopical amide local anaesthetic combination / sodium-channel blocker
PRIMECORE CLASSA
EVIDENCE GRADEA
RESEARCH TOPICSexual Medicine Pharmacology
LAST REVIEWED2026-08-29

What remains unknown?

English translation is not yet verified for 3 excerpt(s). This is a language gap, not an absence of risks or uncertainty.

Read original excerpts (Thai / mixed language)
  • การที่ lidocaine หรือ prilocaine มีใช้เป็นยาชาในบริบทอื่น ไม่ได้ยืนยันข้อบ่งใช้ PE ของทุกผลิตภัณฑ์
  • ไม่ใช่ยารักษาภาวะหย่อนสมรรถภาพทางเพศและไม่แก้ทุกสาเหตุของ PE
  • ไม่ควรเทียบผลของ Fortacin กับผลิตภัณฑ์ผสมออนไลน์ที่ไม่ทราบความเข้มข้น ระบบนำส่ง หรือคุณภาพ

What limits these conclusions?

Insufficient data in the current dataset

This overview does not replace the detailed adverse-event and product-specific risk discussion in the complete Thai profile or the original sources.

02

EVIDENCE BOUNDARY

What this overview does not establish

  • An evidence grade does not rank this molecule against another treatment.
  • A molecule name does not establish the identity, purity or regulatory status of a product.
  • Animal, cell or biomarker findings do not automatically establish human clinical benefit.
  • Approval in one country or indication does not transfer globally.

Where can I check the evidence?

Original sources from the same evidence record used by Compare. Read each source's population, methods, limitations and date; a citation is not product endorsement.

  1. EMA — Fortacin EPAR
  2. EMA — Fortacin product information
  3. EMA — Senstend withdrawn authorisation
  4. EAU — Disorders of ejaculation
03

FAQ · ANSWER ENGINE

Frequently asked questions

What is Lidocaine + Prilocaine?

Lidocaine + Prilocaine is described pharmacologically as Topical amide local anaesthetic combination / sodium-channel blocker. A topical amide local-anaesthetic combination; the specific Fortacin product is authorised in the EU for primary lifelong premature ejaculation in adult men, without extending that status to every cream or spray.

Does Lidocaine + Prilocaine have strong evidence?

PrimeCoreBio records Evidence Grade A. This grade describes evidence strength, not comparative effectiveness or suitability for an individual.

Is Lidocaine + Prilocaine approved everywhere?

No global conclusion should be inferred. PrimeCore Class A must be read with the exact product, country and indication on the source-rich profile.

Medical Disclaimer

Educational information only. This page does not provide diagnosis, treatment, prescribing, dosage, injection instructions or individual medical advice.

Contact PrimeCoreBio

Choose a contact channel

General information only · No sales or medical advice